SMTL ID : 1vj9.1

Urokinase Plasminogen Activator B-Chain-JT464 Complex

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 5 residues within 4Å: Chain A: H.110, N.111, T.193, K.195, M.196 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:N.111 Salt bridges: A:H.110, A:K.195 SO4.2: 6 residues within 4Å: Chain A: V.45, H.61, Q.210, G.211, S.213 Ligands: 5IN.3 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:G.211, A:S.213, A:S.213, A:S.213 Salt bridges: A:H.61

1 x 5IN: N-(BENZYLSULFONYL)-L-SERYL-N~1~-{4-[AMINO(IMINO)METHYL]BENZYL}-O-BENZYL-L-SERINAMIDE(Non-covalent)

5IN.3: 21 residues within 4Å: Chain A: H.61, I.64, Y.102, T.106, L.107, H.109, S.160, D.207, S.208, C.209, Q.210, S.213, V.231, S.232, W.233, G.234, R.235, G.236, C.237, G.244 Ligands: SO4.2 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:I.64, A:V.231 Hydrogen bonds: A:L.107, A:S.208, A:S.232, A:G.234, A:G.234, A:G.236, A:G.236 Water bridges: A:A.238 pi-Stacking: A:H.109

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schweinitz, A. et al., Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agents. J.Biol.Chem. (2004)

Release Date

2004-06-22

Peptides

plasminogen activator, urokinase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
U

plasminogen activator, urokinase

Related Entries With Identical Sequence